Biondvax Pharmaceuticals Ltd. ADR | Balance Sheet
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
19,876.00
11,628.00
35,486.00
25,324.00
71,382.00
20,307.20
Total Accounts Receivable
461.00
1,043.00
1,442.00
764.00
3,923.00
102.50
Other Current Assets
28.00
38.00
-
51.00
-
155.80
Total Current Assets
20,365.00
12,709.00
36,928.00
26,139.00
75,305.00
20,565.50
Net Property, Plant & Equipment
3,285.00
2,638.00
2,044.00
1,443.00
5,510.00
7,559.80
Total Investments and Advances
2,173.00
2,327.00
2,335.00
2,528.00
880.00
189.20
Other Assets
-
788.00
-
-
-
8.80
Total Assets
25,823.00
18,462.00
41,307.00
30,110.00
81,695.00
28,323.30
Accounts Payable
392.00
524.00
-
686.00
6,223.00
Other Current Liabilities
1,390.00
1,289.00
1,699.00
689.00
660.00
Total Current Liabilities
1,782.00
1,813.00
1,699.00
1,375.00
6,883.00
Provision for Risks & Charges
55.00
62.00
69.00
76.00
83.00
Other Liabilities
-
-
5,994.00
3,043.00
8,177.00
Total Liabilities
1,837.00
1,875.00
7,762.00
4,494.00
15,143.00
Common Equity (Total)
23,986.00
16,587.00
33,545.00
25,616.00
56,252.00
Total Shareholders' Equity
23,986.00
16,587.00
33,545.00
25,616.00
56,252.00
Total Equity
23,986.00
16,587.00
33,545.00
25,616.00
56,252.00
Liabilities & Shareholders' Equity
25,823.00
18,462.00
41,307.00
30,110.00
81,695.00
Non-Equity Reserves
-
-
-
-
10,300.00
About Biondvax Pharmaceuticals
View Profile
